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Abstract
Bordetella pertussis is the aetiologic agent of whooping cough, a common cause of severe respiratory illness in children and prolonged
mild cough in adults. To understand some of the reasons for differences in clinical symptoms between adults and children, we measured
B. pertussis DNA loads in nasopharyngeal swabs (NPS) from 19 adults and 40 children (including 14 infants) by quantitative IS481 real-
time PCR. All cases had been pre-diagnosed with the B. pertussis-speciﬁc loop-mediated isothermal ampliﬁcation method. The mean
PCR threshold cycles for adult and child NPS were 34.9 and 27.1, respectively, indicating a signiﬁcantly lower B. pertussis DNA load in
adults than in children (p <0.001). Moreover, adults had very low DNA loads during both early and later stages of the disease. When
corresponding bacterial loads in NPS were calculated for B. pertussis Tohama cells using a standard curve, the mean number of bacterial
cells taken with a rayon-tipped swab from an adult, older child and infant was estimated to be 320 (95% CI 120–910), 2.1 · 104 (95%
CI 5.3 · 103 to 8.3 · 104) and 1.1 · 106 cells (95% CI 1.2 · 105 to 8.9 · 106), respectively. This indicates that the B. pertussis load in
NPS is closely correlated with patient age. Our observations suggest that adult pertussis is characterized by a lower bacterial load in
the nasopharynx, resulting in milder symptoms and negative cultures.
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Introduction
Bordetella pertussis, a highly communicable gram-negative coc-
cobacillus, is the aetiologic agent of whooping cough, which
has been a major acute respiratory infection, resulting in
severe childhood illness and infant death [1]. In Japan, the
incidence of pertussis cases in adolescents and, especially,
adults, has signiﬁcantly increased from the early 2000s; this
has also been seen in other countries with high vaccination
coverage [2]. Adolescents and adults are assumed to be the
primary reservoir of B. pertussis and play a crucial role in the
transmission of the microbe to infants and unvaccinated chil-
dren [3–5]. The clinical symptoms of pertussis in adolescents
and adults vaccinated during childhood are different from
typical presentations in children, and may consist only of a
prolonged cough [6–9]. Moreover, culture of B. pertussis has
a much lower sensitivity for diagnosis of pertussis in adults
than in children [5,9]. Although B. pertussis infection is known
to present differently in adults and children, the differences
in the bacterial load in the nasopharynx remain unclear.
During the last decade, nucleic acid ampliﬁcation tests
have revolutionized the laboratory diagnosis of B. pertussis
infections. Various detection methods, including real-time
PCR and loop-mediated isothermal ampliﬁcation (LAMP),
have been developed that target different regions of B. per-
tussis genome [10–13]. Previously, we developed a LAMP
assay method targeting the pertussis toxin promoter region,
which provided rapid, sensitive and highly speciﬁc detection
of B. pertussis DNA [11], although the ampliﬁcation efﬁciency
is too high to make a quantitative assay of the bacterial load
in clinical specimens. By contrast, real-time PCR targeting
insertion sequence IS481 is a useful tool not only for rapid
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and sensitive diagnosis, but also for quantitative analysis. The
IS481 real-time PCR can detect other Bordetella subspecies,
such as Bordetella holmesii, Bordetella bronchiseptica and Borde-
tella parapertussis, although this assay is now widely used for
the diagnosis of B. pertussis [14,15]. In neonates and young
children with pertussis, the IS481 real-time PCR showed that
the B. pertussis DNA load in nasopharyngeal swabs (NPS)
persists for a long time (3 weeks) after administration of
antimicrobials [16,17]. For other pathogenic agents causing
respiratory tract infections, such as Moraxella catarrhalis and
Streptcoccus pneumoniae, the quantitative changes in bacterial
DNA load in NPS correlate with the numbers of organisms
detected by semiquantitative culture [18,19].
The present study aimed to determine B. pertussis DNA
loads in NPS among adults and children, who were conﬁrmed
to have pertussis by B. pertussis-speciﬁc LAMP assay, by using
quantitative IS481 real-time PCR. We also investigated the
relationship between B. pertussis load and bacterial genotypes.
Materials and Methods
Clinical samples
Approximately 200 NPS were obtained from adults
(‡16 years old) and children (£15 years old) with suspected
pertussis between June 2007 and September 2009. The NPS
were collected with sterilized rayon-tipped swabs (Eiken
Chemical Co., Ltd, Tokyo, Japan) and then transported to
the National Institute of Infectious Diseases, Japan. NPS were
immersed in 0.5 mL of saline, vortexed, and precipitated
by centrifugation (20 000 g for 10 min). Total DNA was
extracted from the precipitation using QIAamp DNA Micro-
kit (Qiagen, Hilden, Germany), and eluted with 25 lL of the
AE elution buffer. The DNA samples were stored at )20C
until used.
LAMP assay
To conﬁrm B. pertussis infection, a B. pertussis-speciﬁc LAMP
assay was performed on DNA samples from NPS as
described previously [11]. The LAMP ampliﬁcation was per-
formed with a 60-min reaction, and conﬁrmed with real-time
monitoring of the increase in turbidity using LA-320C (Eiken
Chemical Co., Ltd). Among the DNA samples tested, 19
from adults and 40 from children (14 infants and 26 older
children) were positive in the LAMP assay (‡0.1 turbidity),
respectively. The vaccination history was obtained in 13
infants and 12 older children, but not in adults. Of 13 infants,
11 (85%) had never been immunized with pertussis vaccine.
By contrast, ten (83%) of 12 older children had received four
doses of pertussis vaccine.
IS481 real-time PCR
Quantitative real-time PCR targeting IS481 was performed
by an Applied Biosystems 7500 Fast Real-Time PCR system
(Applied Biosystems, Foster City, CA, USA) as described
previously [12], with minor modiﬁcations. Brieﬂy, the IS481
real-time PCR ampliﬁcations were done in 20-lL reaction
volumes containing 1· Premix Ex Taq (Perfect Real Time;
Takara Bio Inc., Shiga, Japan), 0.9 lM primer PPert and
APPert, 0.25 lM TaqMan probe SPert, 0.4 lL of 50· Rox
reference dye II, and 2 lL of DNA sample. The PCR condi-
tions were 15 s at 95C, followed by 40 cycles of 95C for
3 s and 57C for 30 s. Real-time data were analyzed by
Sequence Detection Systems software, version 1.4 (Applied
Biosystems). Standard curve was generated with ten-fold
serial dilutions of B. pertussis Tohama DNA from 10 ng
(2.4 · 106 bacterial cells) to 0.1 fg (0.024 bacterial cells). The
number of bacterial cells was calculated with the Tohama
genome size of 4.1 Mbp (2.4 genomic copies/10 fg DNA)
[20].
The sampling efﬁciency of NPS and the presence of PCR
inhibitors were examined by ampliﬁcation of the human
b2-microglobulin gene with primers B2M-TR-1 and B2M-TR-2
[16] using SYBR green-based real-time PCR. Each 12 adult
and child DNA samples, which were randomly selected from
LAMP-positive samples, showed b2-microglobulin Ct values in
the range 15.1–24.8 (mean 21.9) and 19.8–22.3 (mean 21.1),
respectively, conﬁrming that the respective sampling efﬁciency
and PCR inhibition were almost identical between adult and
child NPS samples.
Multilocus sequence typing (MLST)
B. pertussis allelic genes (pertussis toxin ptxA, pertactin prn
and serotype 3 ﬁmbriae ﬁm3) were ampliﬁed directly from
patient DNA samples by nested-PCR. The ﬁrst PCR was
performed in a 15-lL reaction volume containing 1.87 lL
DNA sample, 0.44 mM concentrations of each dNTPs,
0.2 lM concentrations of each primer, and 0.3 U of KOD-
FX DNA polymerase (Toyobo, Osaka, Japan). For the
nested-PCR ampliﬁcation, 1 lL of the ﬁrst PCR product
was added as the template to the PCR mixture containing
the same components described above, except that the
nested primers were used instead of the ﬁrst set of prim-
ers (Table 1). Cycling conditions were: denaturation for
1 min at 94C; 30 cycles of 10 s at 98C, 30 s at 55C,
45 s at 68C; and a postextension of 5 min at 72C. The
PCR products were sequenced with the BigDye terminator
v3.1 cycle sequencing kit on an ABI PRISM 3130xl Genetic
Analyzer (Applied Biosystems). The combined allelic pro-
ﬁles were used to deﬁne MLSTs as described previously
[2].
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Statistical analysis
Data were analyzed using the Mann–Whitney U-test. p <0.05
was considered statistically signiﬁcant.
Results
Sensitivity and speciﬁcity of IS481 real-time PCR
The real-time PCR with ten-fold serial dilutions (0.1 fg to
10 ng) of B. pertussis Tohama DNA was able to detect bacte-
rial DNA over a linear range between 10 fg (2.4 bacterial
cells) and 10 ng (2.4 · 106 bacterial cells) per reaction mix-
ture (r2 = 0.99) (Fig. 1). On the basis of three independent
experiments, the detection limit was a threshold cycle (Ct) of
37.6 ± 0.3, corresponding to 2.4 cells of the Tohama. The
analytical sensitivity of the IS481 real-time PCR was equal to
that of the B. pertussis-speciﬁc LAMP assay [11].
Fifty-nine LAMP-positive (19 adults and 40 children) and
24 LAMP-negative DNA samples (six adults and 18 children,
randomly selected) were subjected to the IS481 real-time
PCR. The LAMP-positive samples had Ct values in the range
14.6–39.5 (mean 29.7). By contrast, when the real-time PCR
assay was applied to the LAMP-negative samples, the Ct val-
ues were in the range 37.2–40 (mean 39.7) (data not shown).
Twenty (83%) of 24 LAMP-negative samples had a Ct value
of 40 (i.e. no detectable ampliﬁcation). The IS481 real-time
PCR and LAMP results showed a high level of agreement
(77/83; 93%) with 55/83 found to be positive in both assays
and 22/83 found to be negative in both assays, when a Ct
value >37.6 was used as the cut-off for the real-time PCR.
B. pertussis DNA loads among children and adults
Figure 2a shows Ct values of LAMP-positive DNA samples
from 40 children (mean age 6.0 years; age range 0–15 years)
and 19 adults (mean age 43.3 years; age range 22–83 years).
The child samples had Ct values in the range 14.6–39.5 (mean
TABLE 1. Primers used in multilocus sequence typing
analysis
Target
gene
Primer
name Sequence (5¢- to 3¢) PCR Coordinatea
ptxA ptx-outerF TAACGCGGGTCTATCACAAC 1st 3988790
ptx-outerR TAGAACGAATACGCGATGCT 1st 3989047
ptx-innerF GACCACGACCACGGAGTATT 2nd 3988824
ptx-innerR GTACACGAGAACCATCGCCT 2nd 3989021
prn prn-AF GCCAATGTCACGGTCCAA 1st 1098595
prn-AR GCAAGGTGATCGACAGGG 1st 1099163
prn-innerF GTCATTGCAGCCGGAAGACC 2nd 1098657
prn-innerR CCGGTCTCGATGACATTGCC 2nd 1099111
ﬁm3 Fim3-F1 ATGTCCAAGTTTTCATACCC 1st 1647602
Fim3-R1 GGTGACCTTGCCGGTAAA 1st 1648082
ﬁm3-innerF CCAGCACCCTCAACCATATC 2nd 1647738
ﬁm3-innerR GGCTTGCGTGGTTTTGTC 2nd 1648055
aCoordinates in Bordetella pertussis Tohama genome sequence NC02929.
FIG. 1. Detection limit for linear calibration of IS481 real-time PCR.
Serial dilutions of Bordetella pertussis Tohama DNA were subjected
to the real-time PCR. Data are the mean ± SD for three indepen-
dent experiments.
(a)
(b)
FIG. 2. Comparison of Bordetella pertussis DNA loads in nasopharyn-
geal swabs among children and adults with pertussis. (a) Children
(infant and older children, n = 40) versus adults (n = 19). (b) Infants
(n = 14) versus older children (n = 26). The DNA samples (2 lL)
were subjected to IS481 real-time PCR. Horizontal bars indicate
mean Ct values.
CMI Nakamura et al. B. pertussis DNA loads among adults and children 367
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 365–370
27.1), whereas the adult samples had signiﬁcantly higher Ct
values in the range 29.1–39.0 (mean 34.9) within a narrow
range. Statistical signiﬁcance was observed with respect to
the Ct values between children and adults (p <0.001).
Figure 2b also shows Ct values of LAMP-positive DNA
samples from 14 infants (mean age 2.9 months; age range 1–6
months) and 26 older children (mean age 9.2 years; age
range 2–15 years). The infant samples had Ct values in the
range 14.6–33.8 (mean 23.6). By contrast, the older child
samples had higher Ct values in the range 18.8–39.5 (mean
29.1) (p 0.011).
The clinical information about cough duration was
obtained from 16 adult patients. Eight adults had a cough
duration of less than 14 days (mean 8.6 days) at the time of
sampling, and other adults had a duration of more than
15 days (mean 30.3 days). The Ct values (mean Ct value of
£14 days, 35.9; >15 days, 34.8) were not statistically signiﬁ-
cant between these two groups (p 0.92) (data not shown).
Relationship of B. pertussis DNA loads and bacterial
genotypes
On the basis of the MLST analysis, Japanese B. pertussis iso-
lates could be classiﬁed into ﬁve genotypes (MLST-1 to
MLST-5), as described previously [2]. Among 40 children
NPS samples, the MLSTs in 33 samples were identiﬁed as: 17
MLST-1 (harboring ptxA2, prn1 and ﬁm3A alleles); 14 MLST-2
(ptxA1, prn2 and ﬁm3A); and two MLST-4 (ptxA1, prn2 and
ﬁm3B). The mean Ct values for MLST-1, -2, and -4 were
27.0, 24.8, and 28.6, respectively. Comparison of Ct values
for MLST-1 and -2 revealed no statistically signiﬁcant differ-
ence (p 0.27) (data not shown). Among the infants and older
children, no correlation was found between B. pertussis DNA
loads and the bacterial genotypes.
Discussion
To our knowledge, this is the ﬁrst report of a precise com-
parative analysis of B. pertussis loads in adults and children.
The results obtained clearly indicate that adults had very low
B. pertussis DNA loads in their NPS compared to children,
especially infants. When bacterial loads in NPS were calcu-
lated for B. pertussis Tohama cells using a standard curve, the
mean numbers of bacterial cells taken with a rayon-tipped
swab from adults, older children and infants were estimated
to be 320 (95% CI 120–910), 2.1 · 104 (95% CI 5.3 · 103 to
8.3 · 104) and 1.1 · 106 cells (95% CI 1.2 · 105 to
8.9 · 106), respectively (Table 2). Surprisingly, the bacterial
numbers in adults were 340-fold and 65-fold lower than
those in infants and older children, respectively. In general,
adults with pertussis showed only prolonged cough illness
and had less typical symptoms than children [3,6–9]. In addi-
tion, vaccinated asymptomatic children had signiﬁcantly fewer
B. pertussis than symptomatic patients [21]. Our experimental
observations strongly suggest that the lower nasopharyngeal
bacterial load in adults is related to the atypical and milder
symptoms in adult pertussis.
Previously, Bidet et al. [16] demonstrated that B. pertussis
DNA loads in NPS decreased progressively during antibiotic
treatment in children. Several factors are also considered to
affect B. pertussis load in the human nasopharynx, including
patient age, previous vaccination or infection, and host
genetic background. In the present study, infants had a larger
B. pertussis DNA load than older children, and most (85%) of
the infants had not received pertussis vaccination, whereas
most (83%) of the older children had received four doses of
the vaccine. Our ﬁndings support the hypothesis that the
B. pertussis DNA load is affected by vaccination. Unfortu-
nately, this does not apply to adults because pertussis vac-
cines are unable to provide lifelong immunity [22]. The
duration of immunity post-vaccination is estimated to be in
the range 4–12 years and, therefore, the bacterial loads
in adults may be affected by other factor(s) besides the
vaccination.
B. pertussis culture has been taken as a gold standard diag-
nostic method because it is highly speciﬁc. However, the cul-
ture has limited sensitivity for previously vaccinated persons,
especially adolescents and adults [5,8,9]. In the present study,
we demonstrated that adults with pertussis had very low
B. pertussis DNA loads in their NPS during both early and
later stages of the cough illness. This ﬁnding suggests that
the diagnosis of pertussis by bacterial culture is difﬁcult in
adults even if NPS are obtained in the early stage of the ill-
ness. Compared with the culture method, nucleic acid ampli-
ﬁcation tests such as IS481-based real-time PCR and
B. pertussis-speciﬁc LAMP provide a highly sensitive proce-
dure for detection of B. pertussis DNA [11,13,14]. On the
basis of our ﬁndings, we recommend the performance of
TABLE 2. Number of Bordetella pertussis cells taken with a
rayon-tipped swab from infant, child and adult patient
Patient
Number
of patients
Mean age
(range)
B. pertussis
cells/swab (95% CI)a
Infant 14 2.9 months
(1–6 months)
1.1 · 106 (1.2 · 105 to 8.9 · 106)
Older child 26 9.2 years
(2–15 years)
2.1 · 104 (5.3 · 103 to 8.3 · 104)
Adult 19 43.3 years
(22–83 years)
320 (120–910)
aBacterial cells were calculated for B. pertussis Tohama cell.
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nucleic acid ampliﬁcation tests for an accurate diagnosis
of pertussis, especially when adult pertussis cases are
suspected.
During the last three decades, genetic divergence in B. per-
tussis has been observed in many countries [23–27]. In Japan,
the circulating strains have shifted mainly from MLST-1 to
MLST-2. The MLST-1 strains include vaccine-types ptxA2 and
prn1 alleles, whereas the MLST-2 strains include nonvaccine-
types ptxA1 and prn2 alleles [2]. This genetic shift has been
speculated to have resulted from adaptation of the bacterial
population to vaccine-induced immunity [23,24,28,29]. The
bacterial load of the emerging MLST-2 strains in the naso-
pharynx has not previously been investigated. We therefore
examined the bacterial DNA loads of MLST-2 and MLST-1
strains but found no association between the DNA loads
and their genotypes among infants and older children. This
would suggest that emerging MLST-2 strains have the ability
to produce similar bacterial loads to those of the the MLST-
1 strains.
In conclusion, the B. pertussis DNA load in NPS depends
highly on patient age. Adults had very low B. pertussis DNA
loads and organism numbers in their NPS during both the
early and later stages of the cough illness, and this explains
the culture-negative results in adult pertussis cases. To make
an accurate diagnosis of adult pertussis, nucleic ampliﬁcation
tests such as the IS481 real-time PCR and B. pertussis-speciﬁc
LAMP assays are recommended as sensitive methods.
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